finalfullthesisdjpotter

Recommendations

Info

Abbreviations ACMD Advisory Council on the Misuse of Drugs ANOVA Analysis of Variance API Active pharmaceutical ingredient B D /B D Homozygous CBD chemotype B D /B T Heterozygous mixed THC/CBD chemotype BDS Botanical Drug Substance BMA British Medical Association BRM Botanical Raw Material B T /B T Homozygous THC chemotype cAMP cyclic Adenosine 5’- monophosphate CB 1 and CB 2 Cannabinoid Receptors 1 and 2 CBC Cannabichromene CBCA Cannabichromenic acid CBCV Cannabichromevarin CBCVA Cannabichromevarinic acid CBD Cannabindiol xxvii
CBDA Cannabidiolic acid CBG Cannabigerol CBGA Cannabigerolic Acid CBN Cannabinol CI Confidence Interval CNS Central Nervous System EMEA European Medicines Agency ERK Extra-cellular regulated kinase ETP Enriched trichome preparation GC Gas chromatography GAP Good Agricultural Practise GDP Guanosine 5’-diphosphate GMP Good Manufacturing Practice GTP Guanosine 5’-triphosphate GWP Good Wild crafting Practice HPLC High Performance Liquid Chromatography HPS High Pressure Sodium xxviii
Page 1 and 2: THE PROPAGATION, CHARACTERISATION A
Page 3 and 4: Cannabis sativa L cv Gayle CBD Chem
Page 5 and 6: List of Publications Potter, D.J.,
Page 7 and 8: CHAPTER 2 CHARACTERISATION OF ILLIC
Page 9 and 10: 3.5.3 Effect of capitate stalked tr
Page 11 and 12: 5.4.2.7 Plant Weight Assessment ...
Page 13 and 14: 6.7.3.4. Effect of Harvest Date and
Page 15 and 16: Figure 2.4. (a) A herb grinder in c
Page 17 and 18: Figure 3.11. (a) Secretory cells st
Page 19 and 20: Figure 3.23. The mean CBN content (
Page 21 and 22: Figure 5.12. Effect of Daylength on
Page 23 and 24: List of Tables Table 1.1. Examples
Page 25 and 26: Table 4.9. The cannabinoid profile
Page 27: Table 6.6. A comparison of the terp
Page 31 and 32: xxx
Page 33 and 34: Chapter 1 Introduction According to
Page 35 and 36: Chapter 1 Introduction commenced cl
Page 37 and 38: Chapter 1 Introduction Pakistan to
Page 39 and 40: Chapter 1 Introduction containing a
Page 41 and 42: Chapter 1 Introduction 1999a). Most
Page 43 and 44: Chapter 1 Introduction prohibition
Page 45 and 46: Chapter 1 Introduction GW Pharmaceu
Page 47 and 48: Chapter 1 Introduction proportion o
Page 49 and 50: Chapter 1 Introduction cannabigerov
Page 51 and 52: Chapter 1 Introduction monoterpenes
Page 53 and 54: Chapter 1 Introduction endocannabin
Page 55 and 56: Chapter 1 Introduction glutamate ot
Page 57 and 58: Chapter 1 Introduction Six, the dif
Page 59 and 60: Chapter 2 Characterisation of Illic
Page 79 and 80:
Chapter 3. Cannabis trichome form,
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Chapter 4. The Function and Exploit
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Chapter 5. Indoor Propagation of Me
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Chapter 6. The Outdoor Propagation
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Chapter 7 General Discussion Chapte
Page 207 and 208:
Chapter 7 General Discussion be at
Page 209 and 210:
Chapter 7 General Discussion to be
Page 211 and 212:
Chapter 7 General Discussion photos
Page 213 and 214:
Chapter 7 General Discussion that a
Page 215 and 216:
Chapter 7 General Discussion who ha
Page 217 and 218:
References Baker, R., 2002. Commerc
Page 219 and 220:
References Cerniak, L., 1985. The G
Page 221 and 222:
References Dayanandan, P. & Kaufman
Page 223 and 224:
References Fairbairn, J.W., 1972. T
Page 225 and 226:
References Ghosal, S., Singh, S., B
Page 227 and 228:
References Henderson, S.M., 1973. E
Page 229 and 230:
References Johnson, J.R. and Potts,
Page 231 and 232:
References Mahlberg, P.G., Hammond,
Page 233 and 234:
References de Meijer, E.D.M., 1994.
Page 235 and 236:
References Page, C.P., Hoffman, B.,
Page 237 and 238:
References Raman, A.R., 1998. The C
Page 239 and 240:
References Russo, E. B., Jiang, H.
Page 241 and 242:
References Struik, P.C., Amaducci,
Page 243 and 244:
References UNODC. United Nations Of
Page 245 and 246:
References Wilkinson, T. J., 2006.
Page 247 and 248:
Appendix 8.1 Analysis of cannabinoi
Page 249 and 250:
Appendix 8.1 Analysis of cannabinoi
Page 251 and 252:
Appendix 8.2 Analysis of terpene co
Page 253 and 254:
Appendix 8.3 A Comparison of the St
Page 255:
Appendix 8.5 Definitions of Social
show all

finalfullthesisdjpotter

Create successful ePaper yourself

Delete template?

Save as template?